Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
NEXIEN BIOPHARMA, INC. (NXEN) had Return on Tangible Equity of 66.19% for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-0.24M |
|
-- |
|
-- |
|
$0.16M |
|
$-0.16M |
|
$-0.08M |
|
$-0.24M |
|
$-0.24M |
|
$-0.24M |
|
$-0.24M |
|
$-0.24M |
|
$-0.24M |
|
$-0.16M |
|
$-0.13M |
|
66.19M |
|
66.19M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$0.37M |
|
-- |
|
-- |
|
$0.37M |
|
$-0.36M |
|
$-0.36M |
|
$-0.36M |
|
70.47M |
|
| Cash Flow Statement Financials | |
$-0.06M |
|
-- |
|
$0.03M |
|
$0.04M |
|
$0.00M |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
-0.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
66.19% |
|
|
Return on Tangible Equity |
66.19% |
-5716.30% |
|
66.19% |
|
$-0.01 |
|
$-0.00 |
|
$-0.00 |
|